• Latest
  • Trending
  • All
  • News
  • Business
  • Lifestyle
GOP Senator Shares He Participated in a COVID-19 Vaccine Trial To Boost the Public’s Confidence

GOP Senator Shares He Participated in a COVID-19 Vaccine Trial To Boost the Public’s Confidence

November 17, 2020
TOM BASILE: The Real War Is With Communist China

TOM BASILE: The Real War Is With Communist China

July 2, 2025
Dems Resort To Cringe Theatrics As Trump’s ‘Big, Beautiful’ Bill Rolls Toward Finish Line

Dems Resort To Cringe Theatrics As Trump’s ‘Big, Beautiful’ Bill Rolls Toward Finish Line

July 2, 2025
Mike Johnson Touts ‘Forward Momentum’ As Megabill Vote Put On Ice

Mike Johnson Touts ‘Forward Momentum’ As Megabill Vote Put On Ice

July 2, 2025
Jetsetting Elites Can Now Make Tax-Exempt Donations Directly To Their Favorite Disruptive Eco-Activists

Jetsetting Elites Can Now Make Tax-Exempt Donations Directly To Their Favorite Disruptive Eco-Activists

July 2, 2025
CIA Has Begun Job Cuts

CIA Report Slams Investigation into Russia’s Support of Trump

July 2, 2025
Judge Orders Block on Trump Executive Order Restricting Asylum Access at Southern Border

Judge Orders Block on Trump Executive Order Restricting Asylum Access at Southern Border

July 2, 2025
Military Veteran Pardoned for J6 Gets Life Sentence for FBI Attack Plot

Military Veteran Pardoned for J6 Gets Life Sentence for FBI Attack Plot

July 2, 2025
Intel Suggests Iranian Nuclear Program Set Back ‘One To Two Years’, Pentagon Spox Says

Intel Suggests Iranian Nuclear Program Set Back ‘One To Two Years’, Pentagon Spox Says

July 2, 2025
DAVID BLACKMON: Senate Passage Of The OBBBA Involved High Drama Around IRA Subsidies

DAVID BLACKMON: Senate Passage Of The OBBBA Involved High Drama Around IRA Subsidies

July 2, 2025
Some Liberals Would Apparently Rather Protest Trump Than Celebrate America On July 4

Some Liberals Would Apparently Rather Protest Trump Than Celebrate America On July 4

July 2, 2025
Judge Rules Trump Admin Can’t Block Asylum Claims For Migrants Who Cross Southern Border

Judge Rules Trump Admin Can’t Block Asylum Claims For Migrants Who Cross Southern Border

July 2, 2025
Trump Admin Puts Kibosh On Schools Using Taxpayer Dollars To Indoctrinate Kids

Trump Admin Puts Kibosh On Schools Using Taxpayer Dollars To Indoctrinate Kids

July 2, 2025
  • Donald Trump
  • State of the Union
  • Elon Musk
  • Tariffs
  • Congress
  • Faith
  • Immigration
Wednesday, July 2, 2025
  • Login
IJR
  • Politics
  • US News
  • Commentary
  • World News
  • Faith
  • Latest Polls
No Result
View All Result
IJR
No Result
View All Result
Home IJR

GOP Senator Shares He Participated in a COVID-19 Vaccine Trial To Boost the Public’s Confidence

by Madison Summers
November 17, 2020 at 11:54 am
in IJR
250 2
0
GOP Senator Shares He Participated in a COVID-19 Vaccine Trial To Boost the Public’s Confidence

Gage Skidmore/Flickr

491
SHARES
1.4k
VIEWS
Share on FacebookShare on Twitter

Two pharmaceutical companies have recently announced that their early data in a coronavirus vaccine trial has shown more than 90% efficacy in preventing COVID-19. Americans have previously shown skepticism to receiving a vaccine once it is made available. Now, a Republican senator is sharing a recent decision he made in an effort to boost Americans’ confidence.

Sen. Rob Portman (R-Ohio), 64, shared with Politico that he participated in Johnson & Johnson’s late-stage trial of a COVID-19 vaccine about two weeks ago.

“My hope is that people will stop criticizing the best scientists in the world who are at the FDA — who by the way are following the science — and instead encourage people to step up and be involved in these trials and to get vaccinated,” the Ohio lawmaker told the outlet.

This marks the first time a member of Congress has participated in a coronavirus vaccine trial.

Portman said a Gallup poll published in October was “very concerning,” which showed an 11% drop in Americans’ eagerness to get a COVID-19 vaccine once made available. The poll showed only 50% in September would get the vaccine if approved by the Food and Drug Administration (FDA) and at no cost, down from 61% in August.

The Congressman received the shot on Nov. 5 in the single-dose trial, and he is not sure if he received the placebo or the vaccine candidate.

His remarks come shortly after Moderna announced it had found its experimental vaccine to be 94.5% effective. Pfizer and BioNTech’s potential vaccine also showed more than 90% efficacy in preventing COVID-19.

I am encouraged by the progress we are seeing in the various vaccine trials.

A testament to the power of American scientific innovation and the support Congress has provided to the development of safe and effective vaccines. https://t.co/uQ9thSZ2N1

— Rob Portman (@senrobportman) November 16, 2020

Portman responded to Moderna’s recent announcement, tweeting, “I am encouraged by the progress we are seeing in the various vaccine trials. A testament to the power of American scientific innovation and the support Congress has provided to the development of safe and effective vaccines.”

Tags: CongressCoronavirus Outbreak
Share196Tweet123
Madison Summers

Madison Summers

IJR, Editor-in-Chief She's been with Independent Journal Review since 2018.

Advertisements

Top Stories June 10th
Top Stories June 7th
Top Stories June 6th
Top Stories June 3rd
Top Stories May 30th
Top Stories May 29th
Top Stories May 24th
Top Stories May 23rd
Top Stories May 21st
Top Stories May 17th

Join Over 6M Subscribers

We’re organizing an online community to elevate trusted voices on all sides so that you can be fully informed.





IJR

    Copyright © 2024 IJR

Trusted Voices On All Sides

  • About Us
  • GDPR Privacy Policy
  • Terms of Service
  • Editorial Standards & Corrections Policy
  • Subscribe to IJR

Follow Us

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Politics
  • US News
  • Commentary
  • World News
  • Faith
  • Latest Polls

    Copyright © 2024 IJR

Top Stories June 10th Top Stories June 7th Top Stories June 6th Top Stories June 3rd Top Stories May 30th Top Stories May 29th Top Stories May 24th Top Stories May 23rd Top Stories May 21st Top Stories May 17th